AETHLON MEDICAL, INC. Derivative Liability, Current
AETHLON MEDICAL, INC. (AEMD) had Derivative Liability, Current of $0 as of 2015-03-31, per its 10-K filed 2015-07-13.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DerivativeLiabilitiesCurrent · last filed 2015-07-13
- 2015-03-31: Derivative Liability, Current $0.00.
- 2014-12-31: Derivative Liability, Current $0.00.
- 2014-09-30: Derivative Liability, Current $0.00.
- 2014-06-30: Derivative Liability, Current $0.00.
| Period end | Derivative Liability, Current |
|---|---|
| 2015-03-31 | $0.00 10-K · filed 2015-07-13 |
| 2014-12-31 | $0.00 10-Q · filed 2015-02-10 |
| 2014-09-30 | $0.00 10-Q · filed 2014-11-10 |
| 2014-06-30 | $0.00 10-Q · filed 2014-08-14 |
| 2014-03-31 | $10.68M 10-K · filed 2015-07-13 |
| 2013-12-31 | $5.58M 10-Q · filed 2014-02-11 |
| 2013-09-30 | $5.86M 10-Q · filed 2013-11-14 |
| 2013-06-30 | $2.89M 10-Q · filed 2013-08-13 |
| 2013-03-31 | $3.59M 10-K · filed 2014-07-15 |
| 2012-12-31 | $1.81M 10-Q · filed 2013-02-12 |
| 2012-09-30 | $3.19M 10-Q · filed 2012-11-13 |
| 2012-06-30 | $2.87M 10-Q/A · filed 2012-08-28 |
| 2012-03-31 | $3.59M 10-K · filed 2013-07-15 |
| 2011-12-31 | $1.25M 10-Q · filed 2012-02-16 |
| 2011-09-30 | $1.34M 10-Q · filed 2011-11-18 |
| 2011-06-30 | $2.22M 10-Q/A · filed 2011-08-22 |
| 2011-03-31 | $2.00M 10-K · filed 2012-06-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |